Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast

British Journal of Cancer

Volumn 74, Issue 7, 1996, Pages 1005-1011

  Al Tubuly, A A ^a   Luqmani, Y A ^b   Shousha, S ^b   Melcher, D ^c   Ritter, M A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Breast tumour; Human interleukin 4 receptor; Hyperplasia; Invasive carcinoma; MAb MR6

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 4 RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST HYPERPLASIA; CANCER GRADING; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL GROWTH; CELL NUCLEUS; CELL SHAPE; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0029785713     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.481     Document Type: Article

References (31)

1. AL-JABAARI B, LADYMAN HM, LARCHÉ M, SIVOLAPENKO GB, EPPENETOS AA AND RITTER MA. (1989). Elevated expression of the Interleukin 4 receptor in carcinoma: a target for immunotherapy? Br. J. Cancer, 59, 910-914.
2. BEVILACQUA G, SOBEL ME, LIOTTA LA AND STEEG PS. (1989). Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49, 5185-5190.
3. BURCHELL J, DURBIN H AND TAYLOR-PAPADIMITRIOU J. (1983). Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J. Immunol., 131, 508-513.
4. BUSSOLATI G, BOTTA G AND GULIOTTA P. (1980). Actin-rich (myoepithelial) cells in ductal carcinoma in situ of the breast. Virchows Arch. (B), 34, 251-259.
5. DE MAAGD R, MACKENZIE W, SCHUURMAN H, RITTER MA, PRICE K, BROEKHUIZEN R AND KATER L. (1985). The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies. Immunology, 54, 745-754.
6. DOWNWARD, J, YARDEN Y, MAYES E, SCRACE G, TOTTY N, STOCKWELL P, ULLRICH A, SCHLESSINGER J AND WATERFIELD M. (1984). Close similarity of epidermal growth factor receptor and erbB-2 oncogene protein sequences. Nature, 307, 521-527.
7. GERDES J, LEMKE H, BAISCH H, WACKER H, SCHWAB U AND STEIN H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715.
8. GUELSTEIN V, TCHYPYSHEVA T, ERMILOVA V, LITVINOVA, L, TROYANOVSKY S AND BANNIKOV G. (1988). Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumours, dysplasias and breast cancer. Int. J. Cancer, 42, 147-153.
9. IMAMI N, LARCHÉ M AND RITTER MA. (1994) Inhibition of alloreactivity by mAb MR6: differential effect on IL-2- and IL-4-producing human T cells. Int. Immunol., 6, 1575-1584.
10. LAEMMLI UK. (1970). Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature, 227, 680-685.
11. LAHM H, SCHNYDER B, WYNIGER J, BORBENYI Z, YILMAZ A, CAR B, FISHCHER J, GIVEL J AND RYFFEL B. (1994). Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors. Int. J. Cancer, 59, 440-447.
12. LARCHÉ M, LADYMAN H AND RITTER MA. (1987). Human thymic epithelial cells and lymphocytes may share common epitopes. In Leukocyte Typing III, McMichael A, Beverly N, Hogg N and Horton M., (eds) pp. 257-259. Oxford University Press: Oxford.
13. LARCHÉ M, LAMB J, O'HEHIR R, IMAMI N, ZANDERS E, QUINT D, MOQBEL R AND RITTER MA. (1988). Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor. Immunology, 65, 617-622.
14. LENNINGTON W, JENSEN R, DALTON L AND PAGE D. (1994). Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer, 73, 118-124.
15. LUQMANI YA, BENNETT C, PATERSON I, CORBISHLEY C, RIO M, CHAMBON P AND RYALL G. (1989). Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int. J. Cancer, 44, 806-812.
16. MAHENDRAN R, MCILHINNEY R, O'HARE M, MONAGHAN P AND GUSTERSON B. (1989). Expression of the common acute lymphoblastic leukaemia antigen (CALLA) in the human breast. Mol. Cell Probes, 3, 39-44.
17. MAT I, LARCHÉ M, MELCHER D AND RITTER MA. (1990). Tumour-associated upregulation of IL-4 receptor complex. Br. J. Cancer, 62, (suppl. x), 96-98.
18. NORTON A, JORDAN S AND YEOMANS P. (1994). Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissue. J. Pathol., 173, 371-379.
19. PAGE DL, DUPONT WD, ROGERS LW AND RADOS MS. (1985). Atypical hyperplasia lesions of the female breast. Cancer, 55, 2698-2708.
20. RUDLAND P AND HUGHES C. (1989). Immunocytochemical identification of cell types in human mammary gland: variations in cellular markers are dependent on glandular topography and differentiation. J. Histochem. Cytochem., 37, 1087-1100.
21. SHI SR, KEY ME AND KALRA KL. (1991). Antigen retrievel in formalin-fixed, paraffin-embedded tissues: an enhancement method for immuno-histochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39, 741-748.
22. SLAMON DL, CLARKE GM, WONG SG, LEVIN WJ, ULLRICH A AND MCGUIRE WL. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182.
23. STEEG P, BEVILACQUA G, POZZATTI R, LIOTTA L AND SOBEL M. (1988). Altered expression of NM23, a gene associated with low tumour metastasis potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res., 48, 6550-6554.
24. TAVASSOI FA AND NORRIS HJ. (1990). A comparison of the results of long-term follow-up for atypical introductal hyperplasia and intraductal hyperplasia of the breast. Cancer, 65, 518-529.
25. TAYLOR-PAPADIMITRIOU J AND LANE E. (1987). Keratin expression in the mammary gland. In The Mammary Gland: Development, Regulation and Function, Neville M and Daniel C (eds) pp. 181-215. Plenum: New York.
26. TEPPER R, PATTENGALE P AND LEDER P. (1989). Murine interleukin-4 displays potent anti-tumour activity in vivo. Cell, 57, 503-512.
27. TOI M, BICKNELL R AND HARRIS AL. (1992). Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res., 52, 275-279.
28. TUNGEKAR MF, TURLEY H, DUNNILL MS, GATTER KC, RITTER MA AND HARRIS AL. (1991) Interleukin-4 receptor expression on human lung tumours and normal lung. Cancer Res., 51, 261-264.
29. TUNGEKAR MF, GATTER KC AND RITTER MA. (1996). Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin-4 receptor (CD 124). Br. J. Cancer, 73, 429-432.
30. ULLRICH A, COUSSENS L, HAYFLICK JS, DULL TJ, GRAY A, TAM AW, LEE J, YARDEN Y, LIBERMANN T AND SCHLESSINGER J. (1984). Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 309, 418-425.
31. VON GAUDECKER B, KENDALL M AND RITTER MA. (1996). Immuno-electron microscopy of the thymic microenvironment. Microscopy Res. Tech., (in press).